EUVIMEDEUVIMED entdecken
Crossref

Aptamer‐Conjugated Nanoparticles: A New Frontier in Gene Delivery for Effective Cancer Treatment

Nilesh Kumar Singh, Abhishek Kumar, Radheshyam Jena, Shreejit Das, Sachin Kumar Singh, Vancha Harish

ChemistrySelect · 2026-07 · 11 (26)

DOI: 10.1002/slct.73805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 07.07.2026. Verfasst von Nilesh Kumar Singh und 5 weiteren Autor:innen. Die Arbeit nennt 168 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the major causes of death worldwide, with significant advancements in treatment strategies. Unfortunately, many standard practices are not tumor‐specific and result in widespread side effects. Aptamer‐regulated nanoparticles represent a novel approach to delivering genes as part of a treatment method. Aptamers are single‐stranded DNA or RNA oligonucleotides that bind to target molecules based on unique affinity and specificity. When combined with nanoparticles, aptamers can allow recognition of cancerous cells and directed delivery of therapeutic genes. Recent clinical trials reported that AS1411 aptamer functionalized nanoparticles resulted in four‐fold greater accumulation of the therapeutic intervention at the tumor site and 65% less off‐target effects when compared to an untargeted delivery strategy. This review provides a complete overview of the development of aptamer‐modified nanoparticle systems for delivering genes as part of a treatment for cancer. This review will identify the different types of aptamers, different types of nanocarriers, conjugation strategies and delivery mechanisms, therapeutic applications, and challenges to improve clinical outcomes and future directions.

Zitieren

APA

Singh, N. K., Kumar, A., Jena, R., Das, S., Singh, S. K., & Harish, V. (2026). Aptamer‐Conjugated Nanoparticles: A New Frontier in Gene Delivery for Effective Cancer Treatment. ChemistrySelect, 11(26). https://doi.org/10.1002/slct.73805

Vancouver

Singh NK, Kumar A, Jena R, Das S, Singh SK, Harish V. Aptamer‐Conjugated Nanoparticles: A New Frontier in Gene Delivery for Effective Cancer Treatment. ChemistrySelect. 2026;11(26). doi:10.1002/slct.73805

BibTeX
@article{Singh2026,
  author = {Singh, Nilesh Kumar and Kumar, Abhishek and Jena, Radheshyam and Das, Shreejit and Singh, Sachin Kumar and Harish, Vancha},
  title = {Aptamer‐Conjugated Nanoparticles: A New Frontier in Gene Delivery for Effective Cancer Treatment},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {26},
  doi = {10.1002/slct.73805}
}
Kostenlos starten →